Dataset Information

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022.

ABSTRACT: Presence of SARS-CoV-2 was monitored in nasopharyngeal samples from young children aged 6-30 months attending day-care centres (DCCs) in Belgium from May 2020-February 2022. SARS-CoV-2 carriage among DCC children was only detected from November 2021, after emergence of Delta and Omicron variants, in 9 of the 42 DCCs screened. In only one DCC, two children tested positive for SARS-CoV-2 at the same sampling time point, suggesting limited transmission of SARS-CoV-2 in Belgian DCCs among young children during the studied period.

SUBMITTER: Van Heirstraeten L

PROVIDER: S-EPMC9137273 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022.

Van Heirstraeten Liesbet L Ekinci Esra E Smet Mathias M Berkell Matilda M Willen Laura L Coppens Jasmine J Spiessens An A Xavier Basil Britto BB Lammens Christine C Verhaegen Jan J Van Damme Pierre P Goossens Herman H Beutels Philippe P Matheeussen Veerle V Desmet Stefanie S Theeten Heidi H Malhotra-Kumar Surbhi S

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20220501 21

Presence of SARS-CoV-2 was monitored in nasopharyngeal samples from young children aged 6-30 months attending day-care centres (DCCs) in Belgium from May 2020-February 2022. SARS-CoV-2 carriage among DCC children was only detected from November 2021, after emergence of Delta and Omicron variants, in 9 of the 42 DCCs screened. In only one DCC, two children tested positive for SARS-CoV-2 at the same sampling time point, suggesting limited transmission of SARS-CoV-2 in Belgian DCCs among young chil ...[more]

PMID: 35620998

Similar Datasets

Project description:SARS-CoV-2 seroprevalence surveys provide critical information to assess the burden of COVID-19, describe population immunity, and guide public health strategies. Early in the pandemic, most of these surveys were conducted within high-income countries, leaving significant knowledge gaps in low-and middle-income (LMI) countries. To address this gap, the U.S. Centers for Disease Control and Prevention (CDC) is supporting serosurveys internationally. We conducted a descriptive analysis of international serosurveys supported by CDC during May 12, 2020-February 28, 2022, using an internal tracker including data on the type of assistance provided, study design, population surveyed, laboratory testing performed, and status of implementation. Since the beginning of the pandemic, CDC has supported 72 serosurveys (77 serosurvey rounds) in 35 LMI countries by providing technical assistance (TA) on epidemiologic, statistical, and laboratory methods, financial assistance (FA), or both. Among these serosurvey rounds, the majority (61%) received both TA and FA from CDC, 30% received TA only, 3% received only FA, and 5% were part of informal reviews. Fifty-four percent of these serosurveys target the general population, 13% sample pregnant women, 7% sample healthcare workers, 7% sample other special populations (internally displaced persons, patients, students, and people living with HIV), and 18% assess multiple or other populations. These studies are in different stages of implementation, ranging from protocol development to dissemination of results. They are conducted under the leadership of local governments, who have ownership over the data, in collaboration with international partners. Thirty-four surveys rounds have completed data collection. CDC TA and FA of SARS-CoV-2 seroprevalence surveys will enhance the knowledge of the COVID-19 pandemic in almost three dozen LMI countries. Support for these surveys should account for current limitations with interpreting results, focusing efforts on prospective cohorts, identifying, and forecasting disease patterns over time, and helping understand antibody kinetics and correlates of protection.

Dataset Information

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022.

Publications

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets